HomeBLISSGVS • NSE
add
Bliss GVS Pharma Ltd
Previous close
₹152.83
Day range
₹150.29 - ₹153.15
Year range
₹106.04 - ₹185.50
Market cap
16.00B INR
Avg Volume
579.03K
P/E ratio
19.08
Dividend yield
0.33%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 1.98B | -0.07% |
Operating expense | 686.80M | 9.76% |
Net income | 155.39M | 269.87% |
Net profit margin | 7.85 | 269.91% |
Earnings per share | — | — |
EBITDA | 192.96M | -29.62% |
Effective tax rate | 28.96% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.41B | 0.70% |
Total assets | 13.01B | 7.37% |
Total liabilities | 2.09B | 0.19% |
Total equity | 10.92B | — |
Shares outstanding | 105.37M | — |
Price to book | 1.53 | — |
Return on assets | — | — |
Return on capital | 2.81% | — |
Cash Flow
Net change in cash
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 155.39M | 269.87% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1984
Website
Employees
966